105 related articles for article (PubMed ID: 11411556)
21. Preparation and evaluation of a new releasable PEGylated tumor necrosis factor-α (TNF-α) conjugate for therapeutic application.
Dai C; Fu Y; Chen S; Li B; Yao B; Liu W; Zhu L; Chen N; Chen J; Zhang Q
Sci China Life Sci; 2013 Jan; 56(1):51-8. PubMed ID: 23314867
[TBL] [Abstract][Full Text] [Related]
22. Effects of recombinant tumor necrosis factor (rHuTNF alpha) on human neutrophils and monocytes: in vitro, ex vivo and in vivo.
Schell-Frederick E; Tepass T; Lorscheidt G; Pfreundschuh M; Schaadt M; Diehl V
Eur J Haematol; 1989 Oct; 43(4):286-96. PubMed ID: 2555213
[TBL] [Abstract][Full Text] [Related]
23. Molecular design of conjugated tumor necrosis factor-alpha: synthesis and characteristics of polyvinyl pyrrolidone modified tumor necrosis factor-alpha.
Kamada H; Tsutsumi Y; Tsunoda S; Kihira T; Kaneda Y; Yamamoto Y; Nakagawa S; Horisawa Y; Mayumi T
Biochem Biophys Res Commun; 1999 Apr; 257(2):448-53. PubMed ID: 10198233
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the growth of transformed cells by human tumor necrosis factor-alpha and interferon-gamma.
Lewis GD; Aggarwal BB; Eessalu TE; Sugarman BJ; Shepard HM
Cancer Res; 1987 Oct; 47(20):5382-5. PubMed ID: 2820567
[TBL] [Abstract][Full Text] [Related]
25. A genetically modified recombinant tumor necrosis factor-alpha conjugated to the distal terminals of liposomal surface grafted polyethyleneglycol chains.
Savva M; Duda E; Huang L
Int J Pharm; 1999 Jul; 184(1):45-51. PubMed ID: 10425350
[TBL] [Abstract][Full Text] [Related]
26. Release profiles of recombinant human tumor necrosis factor from Ca(2+)-triggering liposome in vivo.
Yasui K; Fujioka H; Nakamura Y
Biol Pharm Bull; 1996 Feb; 19(2):246-51. PubMed ID: 8850316
[TBL] [Abstract][Full Text] [Related]
27. Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5'-phosphate.
Yang Z; Sun X; Li S; Tan Y; Wang X; Zhang N; Yagi S; Takakura T; Kobayashi Y; Takimoto A; Yoshioka T; Suginaka A; Frenkel EP; Hoffman RM
Cancer Res; 2004 Aug; 64(16):5775-8. PubMed ID: 15313919
[TBL] [Abstract][Full Text] [Related]
28. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
Cimoli G; Valenti M; Parodi S; Mazzoni A; De Sessa F; Conte P; Russo P
Oncol Res; 1993; 5(8):311-23. PubMed ID: 8012063
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy.
Sersa G; Willingham V; Milas L
Int J Cancer; 1988 Jul; 42(1):129-34. PubMed ID: 3391701
[TBL] [Abstract][Full Text] [Related]
30. Early metabolic response to tumor necrosis factor in mouse sarcoma: a phosphorus-31 nuclear magnetic resonance study.
Shine N; Palladino MA; Patton JS; Deisseroth A; Karczmar GS; Matson GB; Weiner MW
Cancer Res; 1989 Apr; 49(8):2123-7. PubMed ID: 2702653
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of release of granulocyte- and granulocyte-macrophage colony-stimulating factors from phytohemagglutinin-stimulated sorted subsets of human T lymphocytes by recombinant human tumor necrosis factor-alpha. Synergism with recombinant human IFN-gamma.
Lu L; Srour EF; Warren DJ; Walker D; Graham CD; Walker EB; Jansen J; Broxmeyer HE
J Immunol; 1988 Jul; 141(1):201-7. PubMed ID: 2454257
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of tumor necrosis factor-alpha conjugated with polyvinylpyrrolidone on solid tumors in mice.
Kamada H; Tsutsumi Y; Yamamoto Y; Kihira T; Kaneda Y; Mu Y; Kodaira H; Tsunoda SI; Nakagawa S; Mayumi T
Cancer Res; 2000 Nov; 60(22):6416-20. PubMed ID: 11103807
[TBL] [Abstract][Full Text] [Related]
33. Enhanced antitumor potency of polyethylene glycolylated tumor necrosis factor-alpha: a novel polymer-conjugation technique with a reversible amino-protective reagent.
Tsunoda S; Ishikawa T; Yamamoto Y; Kamada H; Koizumi K; Matsui J; Tsutsumi Y; Hirano T; Mayumi T
J Pharmacol Exp Ther; 1999 Jul; 290(1):368-72. PubMed ID: 10381801
[TBL] [Abstract][Full Text] [Related]
34. Synergistic, additive, and antagonistic effects of interleukin-1 beta, tumor necrosis factor alpha, and gamma-interferon on prostaglandin E, hyaluronic acid, and collagenase production by cultured synovial fibroblasts.
Meyer FA; Yaron I; Yaron M
Arthritis Rheum; 1990 Oct; 33(10):1518-25. PubMed ID: 2171539
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant human tumor necrosis factor on human nasopharyngeal carcinoma cell line in vitro.
Ha DK; Lau WH
Cancer Lett; 1988 Aug; 41(2):217-24. PubMed ID: 3401845
[TBL] [Abstract][Full Text] [Related]
37. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor-alpha in rodents.
Patton JS; Peters PM; McCabe J; Crase D; Hansen S; Chen AB; Liggitt D
J Clin Invest; 1987 Dec; 80(6):1587-96. PubMed ID: 3500186
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical and pharmacokinetic characterization of highly potent recombinant L-methionine gamma-lyase conjugated with polyethylene glycol as an antitumor agent.
Takakura T; Takimoto A; Notsu Y; Yoshida H; Ito T; Nagatome H; Ohno M; Kobayashi Y; Yoshioka T; Inagaki K; Yagi S; Hoffman RM; Esaki N
Cancer Res; 2006 Mar; 66(5):2807-14. PubMed ID: 16510603
[TBL] [Abstract][Full Text] [Related]
39. Priming and stimulation of bovine neutrophils by recombinant human interleukin-1 alpha and tumor necrosis factor alpha.
Sample AK; Czuprynski CJ
J Leukoc Biol; 1991 Feb; 49(2):107-15. PubMed ID: 1846902
[TBL] [Abstract][Full Text] [Related]
40. Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice.
Socher SH; Friedman A; Martinez D
J Exp Med; 1988 Jun; 167(6):1957-62. PubMed ID: 3385359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
